Literature DB >> 17526997

Pro-atherogenic alterations in T-lymphocyte subpopulations related to acute hyperglycaemia in type 2 diabetic patients.

Marzena Dworacka1, Hanna Winiarska, Magdalena Borowska, Małgorzata Abramczyk, Teresa Bobkiewicz-Kozlowska, Grzegorz Dworacki.   

Abstract

BACKGROUND: T cells are among the earliest cells to infiltrate the arterial intima during the initial stages of atherosclerosis. Alterations in the peripheral blood lymphocyte distribution might be associated with intensive lymphocytes extravasation and stimulation of atherosclerotic plaque development. Epidemiological data reveal that short-term postprandial hyperglycemia is a significant risk factor for coronary heart disease. Using a parameter that indicates recently-past acute hyperglycemia, 1,5-anhydro-D-glucitol (1,5-AG), the aim of the present study was to elucidate which alterations in peripheral blood T-lymphocytes, if any, are associated with acute hyperglycemia in patients with type 2 diabetes mellitus (DM) and, thus, might be involved in the progression of atherosclerosis. METHODS AND
RESULTS: Measurement of fasting glucose level, glycated hemoglobin A(1c), 1,5-AG, lipid profile and lymphocyte receptors expression (CD3+, CD4+, CD8+, CD8+28+, CD+28 -) was performed in 97 patients with type 2 DM, 23 patients with coronary heart disease, and 15 healthy controls. The mean CD3+, CD4+, CD8+28 - and CD8+28+ lymphocyte counts were significantly higher in the DM patients than in both control groups. Multiple regression analysis revealed that CD4+ and CD8+28- lymphocyte counts primarily were dependent on 1,5-anhydro-D-glucitol plasma levels.
CONCLUSIONS: These results suggest that acute hyperglycemia results in the progression of atherosclerosis in type 2 DM, at least in part through changes in CD4+ and CD8+28- lymphocyte subsets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526997     DOI: 10.1253/circj.71.962

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

1.  Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes.

Authors:  Michael E Widlansky; Jingli Wang; Sherene M Shenouda; Tory M Hagen; Anthony R Smith; Tinoy J Kizhakekuttu; Matthew A Kluge; Dorothee Weihrauch; David D Gutterman; Joseph A Vita
Journal:  Transl Res       Date:  2010-05-11       Impact factor: 7.012

Review 2.  1,5-Anhydroglucitol in diabetes mellitus.

Authors:  Won Jun Kim; Cheol-Young Park
Journal:  Endocrine       Date:  2012-07-31       Impact factor: 3.633

3.  Lower 1,5-anhydroglucitol is associated with denovo coronary artery disease in patients at high cardiovascular risk.

Authors:  Takayuki Fujiwara; Masashi Yoshida; Hodaka Yamada; Takunori Tsukui; Tomohiro Nakamura; Kenichi Sakakura; Hiroshi Wada; Kenshiro Arao; Takuji Katayama; Hiroshi Funayama; Yoshitaka Sugawara; Takeshi Mitsuhashi; Masafumi Kakei; Shin-Ichi Momomura; Junya Ako
Journal:  Heart Vessels       Date:  2014-04-02       Impact factor: 2.037

4.  Diabetes mellitus and accompanying hyperlipidemia are independent risk factors for adhesive capsulitis: a nationwide population-based cohort study (version 2).

Authors:  Sui-Foon Lo; Ssu-Wei Chu; Chih-Hsin Muo; Nai-Hsin Meng; Li-Wei Chou; Wei-Cheng Huang; Chung-Ming Huang; Fung-Chang Sung
Journal:  Rheumatol Int       Date:  2013-08-15       Impact factor: 2.631

5.  Fasting hyperglycemia upon hospital admission is associated with higher pneumonia complication rates among the elderly.

Authors:  Mario R Castellanos; Anita Szerszen; Chadi Saifan; Irina Zigelboym; Georges Khoueiry; Nidal Abi Rafeh; Robert V Wetz; Morton Kleiner; Nelly Aoun; Kera F Weiserbs; Theodore Maniatis; Jeffrey Rothman
Journal:  Int Arch Med       Date:  2010-08-02

6.  Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c.

Authors:  Xiaojing Ma; Xiang Hu; Jian Zhou; Yaping Hao; Yuqi Luo; Zhigang Lu; Yuqian Bao; Weiping Jia
Journal:  Cardiovasc Diabetol       Date:  2015-02-07       Impact factor: 9.951

Review 7.  Inflammation and atherosclerosis: signaling pathways and therapeutic intervention.

Authors:  Peng Kong; Zi-Yang Cui; Xiao-Fu Huang; Dan-Dan Zhang; Rui-Juan Guo; Mei Han
Journal:  Signal Transduct Target Ther       Date:  2022-04-22

8.  Effects of Glucose Fluctuation Targeted Intervention on the Prognosis of Patients with Type 2 Diabetes following the First Episode of Cerebral Infarction.

Authors:  Qingqing Lou; Xiaodan Yuan; Shujie Hao; Joshua D Miller; Juan Yan; Panpan Zuo; Jianing Li; Lihong Yang; Hong Li
Journal:  J Diabetes Res       Date:  2020-01-28       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.